首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

1820622

全球鐵蛋白檢測市場研究報告 - 產業分析、規模、佔有率、成長、趨勢及預測（2025 年至 2033 年）

Global Ferritin Testing Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日期: 2025年07月25日 | 出版商:

Value Market Research | 英文 126 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球鐵蛋白檢測市場預測將大幅成長，預計到 2033 年市場規模將飆升至 19 億美元，較 2024 年的 9.2 億美元大幅成長。這一擴張反映了 2025 年至 2033 年期間預計 8.34% 的驚人年複合成長率(CAGR)。

全球鐵蛋白檢測市場正經歷成長，這得益於人們對缺鐵性貧血及相關疾病認知的不斷提高。鐵蛋白檢測對於診斷鐵狀態和監測治療效果至關重要。免疫測定技術的進步，包括高靈敏度檢測和即時檢測，正在提高診斷的準確性和可及性。未來的發展將著重於多重檢測平台及其與數位健康記錄的整合，以實現全面的患者管理。

此外，慢性病和妊娠相關貧血的盛行率不斷上升，也擴大了對鐵蛋白檢測的需求。預防性醫療保健和常規篩檢計畫的成長進一步推動了市場擴張。自動化和試劑穩定性方面的創新正在提高實驗室效率。隨著診斷能力的提升，鐵蛋白檢測市場將持續發展，提供精準、快速且使用者友好的解決方案。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美各細分市場銷售分析
- 北美各國銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲各細分市場銷售分析
- 歐洲各國銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區分部銷售分析
- 亞太地區國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲各細分市場銷售分析
- 拉丁美洲各國銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲分部銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東和非洲其他地區銷售分析

第9章：鐵蛋白檢測公司的競爭格局

鐵蛋白檢測市場競爭
夥伴關係/合作/協議
併購
新產品發布
其他發展

第10章：公司簡介

頂級公司市佔率分析
市場集中度
Eurolyser Diagnostica GmbH

公司概況
公司收入
產品
最新動態

Cortez Diagnostics Inc

公司概況
公司收入
產品
最新動態

Pointe Scientific Inc

公司概況
公司收入
產品
最新動態

BioMeRieux

公司概況
公司收入
產品
最新動態

Humankind Ventures Ltd

公司概況
公司收入
產品
最新動態

Aviva Systems Biology Corporation

公司概況
公司收入
產品
最新動態

Abnova Corporation

公司概況
公司收入
產品
最新動態

Cosmic Scientific Technologies

公司概況
公司收入
產品
最新動態

CTK Biotech Inc

公司概況
公司收入
產品
最新動態

Thermo Fisher Scientific Inc

公司概況
公司收入
產品
最新動態

注意 - 在公司簡介中，財務細節和最新發展取決於可用性，或者在私人公司的情況下可能不涵蓋

簡介目錄圖表

Product Code: VMR112115397

The forecast for the global Ferritin Testing market predicts substantial growth, with market size projected to soar to USD 1.9 Billion by 2033, a significant increase from the USD 0.92 Billion recorded in 2024. This expansion reflects an impressive compound annual growth rate (CAGR) of 8.34% anticipated between 2025 and 2033.

The global ferritin testing market is experiencing growth driven by increasing awareness of iron deficiency anemia and related disorders. Ferritin assays are critical for diagnosing iron status and monitoring treatment efficacy. Advances in immunoassay technologies, including high-sensitivity and point-of-care testing, are enhancing diagnostic accuracy and accessibility. Future developments will focus on multiplex testing platforms and integration with digital health records for comprehensive patient management.

Moreover, rising prevalence of chronic diseases and pregnancy-related anemia is expanding demand for ferritin testing. The growth of preventive healthcare and routine screening programs is further propelling market expansion. Innovations in automation and reagent stability are improving laboratory efficiency. As diagnostic capabilities advance, the ferritin testing market will continue to evolve, delivering precise, rapid, and user-friendly solutions.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

LIST OF SEGMENTS COVERED

This section of the Ferritin Testing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

Instrument
Reagent
Kits

By Application

Anemia
Hemochromatosis
Lead Poisoning
Pregnancy
Others

By End-use

Hospitals
Diagnostic Laboratories
List of Companies Profiled in the report
Eurolyser Diagnostica GmbH, Cortez Diagnostics Inc., Pointe Scientific Inc., bioMrieux, Humankind Ventures Ltd, Aviva Systems Biology Corporation, Abnova Corporation, Cosmic Scientific Technologies, CTK Biotech Inc., Thermo Fisher Scientific Inc.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. FERRITIN TESTING - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End-use
- 3.7.4 Market Attractiveness Analysis By Regions

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL FERRITIN TESTING MARKET ANALYSIS BY PRODUCT

5.1. Overview By Product
5.2. Historical and Forecast Data Analysis By Product
5.3. Instrument Historic and Forecast Sales By Regions
5.4. Reagent Historic and Forecast Sales By Regions
5.5. Kits Historic and Forecast Sales By Regions

6. GLOBAL FERRITIN TESTING MARKET ANALYSIS BY APPLICATION

6.1. Overview By Application
6.2. Historical and Forecast Data Analysis By Application
6.3. Anemia Historic and Forecast Sales By Regions
6.4. Hemochromatosis Historic and Forecast Sales By Regions
6.5. Lead Poisoning Historic and Forecast Sales By Regions
6.6. Pregnancy Historic and Forecast Sales By Regions
6.7. Others Historic and Forecast Sales By Regions

7. GLOBAL FERRITIN TESTING MARKET ANALYSIS BY END-USE

7.1. Overview By End-use
7.2. Historical and Forecast Data Analysis By End-use
7.3. Hospitals Historic and Forecast Sales By Regions
7.4. Diagnostic Laboratories Historic and Forecast Sales By Regions

8. GLOBAL FERRITIN TESTING MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE FERRITIN TESTING COMPANIES

9.1. Ferritin Testing Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF FERRITIN TESTING INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Eurolyser Diagnostica GmbH
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Cortez Diagnostics Inc
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Pointe Scientific Inc
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. BioMeRieux
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Humankind Ventures Ltd
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Aviva Systems Biology Corporation
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Abnova Corporation
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Cosmic Scientific Technologies
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. CTK Biotech Inc
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. Thermo Fisher Scientific Inc
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments